Methods for Pharmaceuticals and Metabolites in Alphabetic Order
The health and life science sector is research-driven. Every new chemical or biological entity requires to be analyzed in greater detail. HPLC and many other techniques are being used. This section covers a broad range of Methods for Pharmaceuticals and Metabolites. Method development is done mainly in academic research and in researching Pharmaceutical companies. Generic manufacturers worldwide generally inherit the developed methods. Smart pharmaceutical companies invest time in patent extension for one or two years. Please contact us we can be of assistance
- Acetaminophen and Metablolite TI679E_7_8.pdf
- Adenosine phosphates AMP ADP ATP TI691E_1_7_8.pdf
- Adsorbic acid and related compounds by LC-MS TI785E_1_6_7_8_9.pdf
- Analgesics rapid separation 32_7
- Analgesics rapid separation 32_7.pdf
- Analgesics separation 33_7
- Analgesics separation 33_7.pdf
- Angiotesin II Receptor Antagonists by LC_UV 34_1_7
- Angiotesin II Receptor Antagonists by LC_UV 34_1_7.pdf
- Antihistamins 36_1_7
- Antihistamins 36_1_7.pdf
- Antihistamins and Expectorants 37_7
- Antihistamins and Expectorants 37_7.pdf
- Antihistamins Fast Analysis 37_7
- Antihistamins Fast Analysis 37_7.pdf
- Antimigraines selective serotonin antagonists by LC-MS TI832E_1_7_9.pdf
- Antimycins from Marine Sponge Streptomyces by LC HRMS 38_1_7_9
- Antipsychotics by LC-MS TI841E_1_7_8_9.pdf
- Antiretrovirals in Human Mononuclear Cell Extracts by LC-M 39_1_7_9
- Antiretrovirals in Human Mononuclear Cell Extracts by LC-M 39_1_7_9.pdf
- Appetite Suppressants by LC MS 39_1_6_7_9
- Appetite Suppressants by LC MS 39_1_6_7_9
- Arsenobetaine TI702E_1_7_8.pdf
- Artemisins 41_7
- Artemisins 41_7.pdf
- Ascorbic acid and related compounds TI732E_1_6_7_8.pdf
- Aspirin and related Substances I 42_7
- Aspirin and related Substances I 42_7.pdf
- Aspirin and related substances II 43_7
- Aspirin and related substances II 43_7.pdf
- Benzodiazepines from Drugs of Abuse Screen 46_1_7
- Benzodiazepines from Drugs of Abuse Screen 46_1_7.pdf
- Beta Antagonists and diuretics 43_1_7
- Beta Antagonists and diuretics 43_1_7.pdf
- Beta Blockers 45_7
- Beta Blockers 45_7.pdf
- Beta Blockers by LC MS-MS 45_1_7_9
- Beta Blockers by LC MS-MS 45_1_7_9.pdf
- Beta Blockers high pH 44_7
- Beta Blockers high pH 44_7.pdf
- Bisphosphonates by LC-MS TI757E_7_8_9.pdf
- Cannabinoides in Rat Plasma 52_1_7.pdf
- Carglumic Acid in Human Plasma by LC MS-MS 52_1_7_9.pdf
- Catecholamins TI669E_7_8.pdf
- Cefequinome by LC MS-MS 57_7_9.pdf
- Chloramphenicol in Mild by LC MS-MSefequinome by LC MS-MS 57_1_6_7_9.pdf
- Ciprofibrate from Human Plasm by LC MS-MS 57_1_7_9.pdf
- Clenbuterol in Equine Plasma by LC MS-MS 58_1_7_9.pdf
- Clonidine Hydrochloride Oral Solution Containing preservatives 59_1_7.pdf
- Clopidogrel and Photodegradation Products 59_1_7.pdf
- Cold Medicine Analytes I and II 61_7.pdf
- Corticosteroids by LC MS-MS 61_1_7_9.pdf
- Cortisol in Urine by LC MS-MS 62_1_7_9.pdf
- Cytarabine Analogues by Ion Pairing LC M-MS 63_1_7_9.pdf
- Cytotoxic Agents by UHPLC MS-MS 63_1_7_9.pdf
- Didanosine 65_7.pdf
- Diuretic Isocratic 66_1_7.pdf
- Diuretics 66_1_7.pdf
- Dotatate and Octreotide 66_1_7_9.pdf
- Drugs of Abuse Screen by UHPLC MS-MS 68_1_7_9.pdf
- Drugs of abuse screen in urine 250 analytes by LC MS-MS 69_1_7_9.pdf
- Drugs of abuse screenin urine 250 analytes 70_1_7_9.pdf
- Endosulfan isomers TI667E_7_8.pdf
- Entacapone 73_7.pdf
- Epanaolol 73_7.pdf
- Epinastine 73_7.pdf
- Flurbiprofen and related Substances 76_7.pdf
- Formosterol from Human Plasma by LC MS-MS 76_1_7_9.pdf
- Ga-Dotatate QC Analysis By Radiometric Detection 66_1_7.pdf
- Galathiamine 77_7.pdf
- Ginko Biloba Ultra Resolution 78_6_7.pdf
- Ginsenosides from Chinese Medicine by UHPLC MS-MS 78_6_7_9.pdf
- Histamin and related compounds TI682E_1_7_8.pdf
- Hydroxychloroquine in Whole Blood EDTA by LC MS-MS 86_1_7_9.pdf
- Hypertension Therapy Drugs 86_7.pdf
- Ibuprofen and Related Impurities 87_1_7.pdf
- Ibuprofen Chlorpheniramine TI690E_7_8.pdf
- Ibuprofen in Combination with Antihistamine and Decongestant 87_1_7.pdf
- Itraconazole and Hydroxyitraconazole in Whole Blood by LC MS-MS 90_1_7_9.pdf
- Lansoprazole and Degradation Products after Acidic Hydrolysis in 0.1M HCL 91_7.pdf
- Lapatinip Anticancer Drug in Human Plasma by LC MS-MS 91_1_7_9.pdf
- Lidocaine in Saliva by LC MS-MS 92_1_7.pdf
- Lincosamide Antibiotics 92_1_7.pdf
- Local Anaestetics 94_7.pdf
- Lysinoalanine and related compounds by LC-MS TI765E_2_7_8_).pdf
- Nicotine and related compounds by LC-MS TI788E_1_6_7_8_9.pdf
- Nicotine and related compounds by LC-MS TI789E_1_7_8_9.pdf
- Nitrofurane Metabolites by LC MS-MS 106_6_7_9.pdf
- Non Steroidal Ant Inflamatory Drugs 107_1_7.pdf
- Non Steroidal Anti Infamatory Drugs by LC MS-MS 108_1_7_9.pdf
- Non Steroidal Anti Infamatory Drugs Fast Analysis 108_1_7.pdf
- Non Steroidal Anti Inflammatory Drugs II 107_1_7.pdf
- Olanzapine in Human Plasma by LC MS-MS 110_1_7_9.pdf
- Omeprazole and Degradations Product after Acid Hydrolysis in .1 M HCl 110_7.pdf
- Opiates from Drugs of Abuse in Urin by LC MS-MS 111_1_7_9
- OTC Gastric Drugs 114_7.pdf
- Oximetazoline in Nasal Spray Formulation 115_7.pdf
- Paclitaxel 115_7.pdf
- Parabene Preservatives 116_6_7.pdf
- Paracetamol and Related Compounds 116_7.pdf
- Paracetamol and Relates Compounds Enhanced Resolution 117_7.pdf
- Paroxetine and Desfluoro Analogues 119_7.pdf
- Pharmaceutical compounds TI672E_7.pdf
- Pharmaceutically Relevant Compounds 1 133_7.pdf
- Pharmaceutically Relevant Compounds 2 134_7.pdf
- Pharmaceutically RelevantCompounds 3 135_7.pdf
- Pilocarpine 139_7.pdf
- Pravastatin and Isomers by LC MS-MS 142_1_7_9
- Pristinamycine Components in Plasma by LC MS-MS 145_1_7_9.pdf
- Procaine and p Aminobenzoic Acids Separation 146-7.pdf
- Proton Pump Inhibitors (PPIs) 147_7.pdf
- Psychoactive Substances in Synthacaine by LC-UV 148_1_7.pdf
- Quinidine and Quinine and their Hydroderivatives Separation 148_1_7.pdf
- Raniditine Hydrochloride and Related Impurities 149_1_7.pdf
- Sennocides in Traditional Chinese Medicine 151_6_7.pdf
- Serotonin and related compoundsTI683E_1_7_8.pdf
- Sotalol 151_7.pdf
- Statins Pravastins Simvastin 155_1_7.pdf
- Statins Atorvastins Fluvastin 154_1_7.pdf
- Statins in Lactone and Hydroxy Acids forms by HPLC - UV 153_7.pdf
- Steroids Mixture Separation 156_1_7.pdf
- Steroids UHPLC-UV Analysis and Comparisons 156_7.pdf
- Steroids Separation using Enhanced Polar Selectivity 157_1_7.pdf
- Steroids Veterinary by LC MS-MS 157_1_7 _9.pdf
- Sulfonamides 161_1_6_7.pdf
- Telithromycin Analysis 165_1_7.pdf
- Terfenadine and Fexofenadine in Rat Plasma 166_1_7_9.pdf
- Tetracyclines 166_7.pdf
- Tipepidine hibenzate TI532E_7_8.pdf
- Tricyclic Antidepressants 168_1_7.pdf
- Tricyclic Antidepressants Gradient 169_1_7.pdf
- Tricyclic Antidepressants isocratic 169_1_7.pdf
- Triple API Pharmaceutical and Related Substances using Ultra Resolution 171_7.pdf
- USP Monograph Amlodipine Besylate 171_7.pdf
- USP Monograph Budesonide 173_7.pdf
- USP Monograph Estradiol 173_7.pdf
- USP Monograph Ethinylestradiol 172_7.pdf
- USP Monograph Glimepiride 173_7.pdf
- USP Monograph Guaifenesin 174_7.pdf
- USP Monograph Hydrocortisone 174_7.pdf
- USP Monograph Hydroquinone 174_7.pdf
- USP Monograph Indomethacin 174_7.pdf
- USP Monograph Metronidazole 175_7.pdf
- USP Monograph Naproxen 175_7.pdf
- USP Monograph Paracetamol Aspirin Cafeine 175_7.pdf